REFERENCES
1. Chatrath V, Banerjee PS, Goodman GJ, Rahman E. Soft-tissue filler-associated blindness: a systematic review of case reports and case series. Plast Reconstr Surg Glob Open 2019;7:e2173.
2. Liu YC, Tsai MF, Chen YF. Near complete recovery of visual acuity after calcium hydroxylapatite injection-related vision loss: a case report and literature review. Ann Plast Surg 2020;84:S123-7.
3. Master M. Hyaluronic acid filler longevity and localization: magnetic resonance imaging evidence. Plast Reconstr Surg 2021;147:50e-3e.
4. RADIESSE®. Mechanism of Action. Meamy Aesthetics 2021. Available from: https://radiesse.com/hcp/professionals/about-radiesse/how-radiesse-works/ [Last accessed on 26 Aug 2022].
5. RADIESSE®. Injectable implant instructions for use. Franksville, WI: Merz North America Inc.; 2016. Available from: https://radiesse.com/app/uploads/EM00543-04.pdf. [Last accessed on 26 Aug 2022].
6. Jacovella PF. Use of calcium hydroxylapatite (Radiesse) for facial augmentation. Clin Interv Aging 2008;3:161-74.
8. King M, Walker L, Convery C, Davies E. Management of a vascular occlusion associated with cosmetic injections. J Clin Aesthet Dermatol 2020;13:E53-8.
9. Rauso R, Sesenna E, Fragola R, Zerbinati N, Nicoletti GF, Tartaro G. Skin necrosis and vision loss or impairment after facial filler injection. J Craniofac Surg 2020;31:2289-93.
10. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
11. Sung MS, Kim HG, Woo KI, Kim YD. Ocular ischemia and ischemic oculomotor nerve palsy after vascular embolization of injectable calcium hydroxylapatite filler. Ophthalmic Plast Reconstr Surg 2010;26:289-91.
12. Czyz C, Allen SH. Injection filler, vascular occlusion, and tissue necrosis. Otolaryngol Head Neck Surg 2011;145:P139-P139.
13. Kim YJ, Choi KS. Bilateral blindness after filler injection. Plast Reconstr Surg 2013;131:298e-9e.
14. Chang TY, Pan SC, Huang YH, Hsueh YY. Blindness after calcium hydroxylapatite injection at nose. J Plast Reconstr Aesthet Surg 2014;67:1755-7.
15. Hsiao SF, Huang YH. Partial vision recovery after iatrogenic retinal artery occlusion. BMC Ophthalmol 2014;14:120.
16. Chou CC, Chen HH, Tsai YY, Li YL, Lin HJ. Choroid vascular occlusion and ischemic optic neuropathy after facial calcium hydroxyapatite injection - a case report. BMC Surg 2015;15:21.
17. Hsieh YH, Lin CW, Huang JS, Yeh PT. Severe ocular complications following facial calcium hydroxylapatite injections: two case reports. Taiwan J Ophthalmol 2015;5:36-9.
18. Cohen E, Yatziv Y, Leibovitch I, et al. A case report of ophthalmic artery emboli secondary to Calcium Hydroxylapatite filler injection for nose augmentation - long-term outcome. BMC Ophthalmol 2016;16:98.
19. Glass LR, Choi CJ, Lee NG. Orbital complication following calcium hydroxylapatite filler injection. Ophthalmic Plast Reconstr Surg 2017;33:S16-7.
20. Marumo Y, Hiraoka M, Hashimoto M, Ohguro H. Visual impairment by multiple vascular embolization with hydroxyapatite particles. Orbit 2018;37:165-70.
21. Sung WI, Tsai S, Chen LJ. Ocular complications following cosmetic filler injection. JAMA Ophthalmol 2018;136:e180716.
22. Vu PQ, Grob SR, Tao JP. Light perception vision recovery after treatment for calcium hydroxylapatite cosmetic filler-induced blindness. Ophthalmic Plast Reconstr Surg 2018;34:e189-92.
23. Oh DJ, Jiang Y, Mieler WF. Ophthalmic artery occlusion and subsequent retinal fibrosis from a calcium hydroxylapatite filler injection. J Vitreoretin Dis 2019;3:190-3.
24. Georgescu D, Jones Y, McCann JD, Anderson RL. Skin necrosis after calcium hydroxylapatite injection into the glabellar and nasolabial folds. Ophthalmic Plast Reconstr Surg 2009;25:498-9.
26. Dayan SH, Arkins JP, Mathison CC. Management of impending necrosis associated with soft tissue filler injections. J Drugs Dermatol 2011;10:1007-12.
27. Beer K, Downie J, Beer J. A treatment protocol for vascular occlusion from particulate soft tissue augmentation. J Clin Aesthet Dermatol 2012;5:44-7.
28. Darling MD, Peterson JD, Fabi SG. Impending necrosis after injection of hyaluronic acid and calcium hydroxylapatite fillers: report of 2 cases treated with hyperbaric oxygen therapy. Dermatol Surg 2014;40:1049-52.
29. Tracy L, Ridgway J, Nelson JS, Lowe N, Wong B. Calcium hydroxylapatite associated soft tissue necrosis: a case report and treatment guideline. J Plast Reconstr Aesthet Surg 2014;67:564-8.
30. Schuster B. Injection rhinoplasty with hyaluronic acid and calcium hydroxyapatite: a retrospective survey investigating outcome and complication rates. Facial Plast Surg 2015;31:301-7.
31. Dominguez S, Moshrefi S, Dobke M. Treatment protocol for acute arterial occlusion secondary to facial revolumization procedures. Emerg Med 2017;49:221-9.
32. Rocha ACNA & Hirano CF. Extravascular occlusion with calcium hydroxyapatite filler efficiently treated with hyaluronidase. Poster presented at: 24th World Congress of Dermatology; 2019. doi:10.13140/RG.2.2.29506.73923.
33. Uittenbogaard D, Lansdorp CA, Bauland CG, Boonstra O. Hyperbaric oxygen therapy for dermal ischemia after dermal filler injection with calcium hydroxylapatite: a case report. Undersea Hyperb Med 2019;46:207-10.
34. Schelke L, Decates T, Kadouch J, Velthuis P. Incidence of vascular obstruction after filler injections. Aesthet Surg J 2020;40:NP457-60.
35. van Loghem J, Funt D, Pavicic T, et al. Managing intravascular complications following treatment with calcium hydroxylapatite: an expert consensus. J Cosmet Dermatol 2020;19:2845-58.
36. Williams MN, Burgess C. Management of calcium hydroxyapatite vascular occlusion in a hemophiliac with HIV-associated facial lipoatrophy. Dermatol Surg 2021;47:1173-4.
37. Hwang CJ, Morgan PV, Pimentel A, Sayre JW, Goldberg RA, Duckwiler G. Rethinking the role of nitroglycerin ointment in ischemic vascular filler complications: an animal model with ICG imaging. Ophthalmic Plast Reconstr Surg 2016;32:118-22.
38. thiosulfate injection dissolves calcium hydroxylapatite particles: an animal study. J Am Acad Dermatol 2018;79:AB265.
39. Robinson DM. In vitro analysis of the degradation of calcium hydroxylapatite dermal filler: a proof-of-concept study. Dermatol Surg 2018;44 Suppl 1:S5-9.
40. Danysz W, Nowag B, Hengl T, et al. Can sodium thiosulfate act as a reversal agent for calcium hydroxylapatite filler? Clin Cosmet Investig Dermatol 2020;13:1059-73.
41. Yankova M, Pavicic T, Frank K, et al. Intraarterial degradation of calcium hydroxylapatite using sodium thiosulfate - an in vitro and cadaveric study. Aesthet Surg J 2021;41:NP226-36.
42. DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J 2014;34:584-600.
43. Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg 2009;35 Suppl 2:1672-80.
44. Lazzeri D, Agostini T, Figus M, Nardi M, Pantaloni M, Lazzeri S. Blindness following cosmetic injections of the face. Plast Reconstr Surg 2012;129:995-1012.
45. Carruthers JDA. Commentary on: a guide to doppler ultrasound analysis of the face in cosmetic medicine. Aesthet Surg J 2021;41:NP1645-6.
46. Velthuis PJ, Jansen O, Schelke LW, et al. A guide to doppler ultrasound analysis of the face in cosmetic medicine. part 2: vascular mapping. Aesthet Surg J 2021;41:NP1633-44.
47. Loghem JAJ, Humzah D, Kerscher M. Cannula versus sharp needle for placement of soft tissue fillers: an observational cadaver study. Aesthet Surg J 2017;38:73-88.
48. Yeh LC, Fabi SG, Welsh K. Arterial penetration with blunt-tipped cannulas using injectables: a false sense of safety? Dermatol Surg 2017;43:464-7.
49. Pavicic T, Webb KL, Frank K, Gotkin RH, Tamura B, Cotofana S. Arterial wall penetration forces in needles versus cannulas. Plast Reconstr Surg 2019;143:504e-12e.
50. Kim J. Novel forehead augmentation strategy: forehead depression categorization and calcium-hydroxyapatite filler delivery after tumescent injection. Plast Reconstr Surg Glob Open 2018;6:e1858.
51. Casabona G. Blood aspiration test for cosmetic fillers to prevent accidental intravascular injection in the face. Dermatol Surg 2015;41:841-7.
52. Loghem JA, Fouché JJ, Thuis J. Sensitivity of aspiration as a safety test before injection of soft tissue fillers. J Cosmet Dermatol 2018;17:39-46.
53. Cugati S, Varma DD, Chen CS, Lee AW. Treatment options for central retinal artery occlusion. Curr Treat Options Neurol 2013;15:63-77.
54. Seethapathy H, Brandenburg VM, Sinha S, El-Azhary RA, Nigwekar SU. Review: update on the management of calciphylaxis. QJM 2019;112:29-34.
55. Kirby JP, Snyder J, Schuerer DJE, Peters JS, Bochicchio GV. Essentials of hyperbaric oxygen therapy: 2019 review. Mo Med 2019;116:176-9.
56. Dhaliwal A, Gupta M. PDE5 inhibitors. [Updated 2021 Jun 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549843/ [Last accessed on 26 Aug 2022].
57. Hew MR, Gerriets V. Prostaglandin E1. [Updated 2021 Apr 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK546629/?report=classic [Last accessed on 26 Aug 2022].
58. Khan KM, Patel J, Schaefer TJ. Nifedipine. [Updated 2021 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537052/ [Last accessed on 26 Aug 2022].
59. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 1999;128:733-8.
60. Mac Grory B, Schrag M, Biousse V, et al. Management of central retinal artery occlusion: a scientific statement from the american heart association. Stroke 2021;52:e282-94.
61. Prado G, Rodríguez-Feliz J. Ocular pain and impending blindness during facial cosmetic injections: is your office prepared? Aesthetic Plast Surg 2017;41:199-203.
62. Feltgen N, Neubauer A, Jurklies B, et al. Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1: EAGLE study report no. 1. Graefes Arch Clin Exp Ophthalmol 2006;244:950-6.
